Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Foul-mouthed rant at PETA
33 dirt bikes, ATVs seized
Captain America 4 renamed
To join presidential race
Chris Licht out at CNN
6,000-yr-old wood carving
Former Fla. deputy on trial
'AI to save the world'
First known 'virgin birth'
Ban on Nazi symbols
CN bans 10 snooker players
'Thor 4 too silly'
First trailer released
Tons of glue spills on road
80-yr-old climber dies
Singer gets Golden Buzzer
Wins EU trademark dispute
Messi to join Inter Miami
Man stabs teen 15 times
‘Do not disturb’
Christie blasts Trump
Duterte critic bail denied
New ad rules spark outrage
Platonic co-parenting
Uses OpenAI's ChatGPT
Recyclable waste as fees
Volvo debuts EX30
Rishi Sunak arrives in US
Air India jet lands in RU
Swiatek reaches semifinal
US trade deficit widens
EU OK's first RSV vaccine
The Iron Sheik dies at 81
Jury convicts Oregon man
25 years of SATC
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
958 results
Hosted on MSN29d
Moderna's CEO defends the decision to more than quadruple the price of the COVID vaccine and charge around $130 in Senate hearing
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at ...
9hon MSN
Moderna, Pfizer sued over technology developed by Scripps researchers that made COVID-19 vaccine possible
The two lawsuits against Moderna, Pfizer and its partner BioNTech alleges patent infringement related to the mRNA technology ...
The Motley Fool29d
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...
23hon MSN
Moderna, Pfizer hit with new patent lawsuits over COVID vaccines
Biotech firm Promosome LLC sued Moderna , Pfizer and BioNTech , in federal court in San Diego, California, on Tuesday, ...
CNBC15d
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...
Benzinga.com7h
Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech
Promosome, the exclusive licensee of the ’179 patent, disclosed and taught its method of increasing protein expression to Moderna, but Moderna declined to license it. Also Read: US Court Favors ...
WGBH26d
Harvard Docs Protest For Global Vaccine Access At Moderna CEO's Home
Protesters gathered Wednesday afternoon outside the Beacon Hill home of the Moderna CEO Stéphane Bancel, calling on the company to make the technology behind its COVID-19 vaccine ... capacity to ...
Fox Business5d
moderna inc.
Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...
Healthline19d
Covid Arm After Moderna or Pfizer Shot: What to Know
COVID arm is a harmless delayed skin reaction to the COVID vaccine. It happens about one week after the first or second shot of the Moderna vaccine but may also occur after Pfizer. If you didn’t ...
The New York Times11d
Covid-19 Vaccines
By Campbell Robertson Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus. But the trial enrolled fewer participants than expected as new Covid vaccines were ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback